U07.1
Conditions
Interventions
Group 1: • inclusion of children / adolescents with
o positive detection of SARS-CoV-2 (naso- / oropharyngeal test or stool) or
o Detection of antibodies against SARS-CoV-2 or
o Urgent suspicion of a
Sponsors
Universitätskinderklinik im St.-Josef Hospital Klinikum der Ruhr-Universität-Bochum
Eligibility
Sex/Gender
All
Age
No minimum to 18 Years
Inclusion criteria
Inclusion criteria: - inclusion of children / adolescents with o positive detection of SARS-CoV-2 (naso- / oropharyngeal test or stool) or o Detection of antibodies against SARS-CoV-2 or o Urgent suspicion of a recent COVID-19 infection (e.g. if parents tested positive but the children were not tested) - signed declaration of consent - Mothers or other family members (fathers, siblings) of the subjects primarily included (of all ages from 6 months)
Exclusion criteria
Exclusion criteria: - no consent (from parents) to participate in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| In the group of subjects who are tested positive at the time of inclusion (corona outpatient clinic), a seroconversion rate of 70-80% will be detectable. | — |
Secondary
| Measure | Time frame |
|---|---|
| In children and adolescents suffering from COVID19 or those who were tested positive, late effects will be detectable in approx. 5% of these cases. | — |
Countries
Germany
Contacts
Public ContactCorkid Studienteam
Universitätskinderklinik Bochum
Outcome results
None listed